Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jun 1;183(6):2533-40.
doi: 10.1084/jem.183.6.2533.

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

Affiliations

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

M F Krummel et al. J Exp Med. .

Abstract

While interactions between CD28 and members of the B7 family costimulate and enhance T cell responses, recent evidence indicates that the CD28 homologue CTLA-4 plays a downregulatory role. The mechanism by which this occurs is not clear, but it has been suggested that CTLA-4 terminates ongoing responses of activated T cells, perhaps by induction of apoptosis. Here we demonstrate that CTLA-4 engagement by antibody cross-linking or binding to B7 inhibits proliferation and accumulation of the primary T cell growth factor, IL-2, by cells stimulated with anti-CD3 and anti-CD28. This inhibition is not a result of enhanced cell death. Rather it appears to result from restriction of transition from the G1 to the S phase of the cell cycle. Our observation that upregulation of both the IL-2R alpha chain and the CD69 activation antigen are inhibited by CTLA-4 engagement supplies further evidence that CTLA-4 restricts the progression of T cells to an activated state. Together this data demonstrates that CTLA-4 can regulate T cell activation in the absence of induction of apoptotic cell death.

PubMed Disclaimer

References

    1. J Immunol. 1980 Dec;125(6):2665-72 - PubMed
    1. Immunity. 1995 Jul;3(1):87-98 - PubMed
    1. Immunogenetics. 1981;14(1-2):53-61 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Feb;82(3):864-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4185-9 - PubMed

Publication types

MeSH terms